XERS - Xeris Biopharma Holdings, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - XERS (1867096)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2022-12-13
XERSEdick Paul RSee RemarksP - Purchase$1.45+20,0001,561,494+1%+$29,000
2022-05-12
XERSEdick Paul RSee RemarksP - Purchase$1.40+100,0001,541,494+7%+$140,380
D
2022-02-22
XERSPrestrelski StevenChief Scientific OfficerS - Sale+OE$2.42-11,228569,780-2%-$27,158
2021-11-15
XERSEdick Paul RSee RemarksP - Purchase$2.28+20,000841,494+2%+$45,664
M
2021-11-11
XERSShannon John Patrick JrSee RemarksP - Purchase$2.10+100,000363,829+38%+$209,500
2021-11-11
XERSEdick Paul RSee RemarksP - Purchase$2.08+200,000821,494+32%+$415,760
2021-11-10
XERSPieper StevenSee RemarksP - Purchase$2.00+25,000183,108+16%+$49,918

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top